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From 1994 through 2005, gastroenteritis outbreaks
caused by norovirus generally increased in the
Netherlands, with 3 epidemic seasons associated with new
GGII.4 strains. Increased percentages of GGII.4 strains
during these epidemics, followed by a sharp decrease in
their absolute and relative numbers, suggest development
of immunity.
N
oroviruses (NoVs) cause large outbreaks of gastroen-
teritis in settings of close human contact such as hos-
pitals, institutions, military bases, and cruise ships, as well
as sporadic cases. In recent years, human NoVs have
increasingly been recognized as a common cause of gas-
troenteritis. Since the introduction of rapid molecular
detection techniques, a high proportion of acute gastroen-
teritis outbreaks have been attributed to NoVs (1–3). We
describe trends in occurrence of NoV in the Netherlands,
with a focus on the predominant GGII.4 strains.
The Study
Surveillance of viral gastroenteritis outbreaks was ini-
tiated just over a decade ago at the National Institute for
Public Health and the Environment in the Netherlands
(RIVM). Outbreaks were typically reported by the munic-
ipal health service or the food inspection services to the
RIVM, and samples were collected in close collaboration
with these agencies. To determine the role of NoVand pos-
sible differences between different NoV strains in gas-
troenteritis outbreaks, a minimal set of epidemiologic data
(setting, date of onset, number of persons affected, most
probable mode of transmission, and number of hospitaliza-
tions) was collected for reported outbreaks. These data
were supplemented with results of molecular biologic
detection and typing techniques to enable more in-depth
analysis of surveillance data. 
Preliminary typing of strains was performed by
sequencing region A(280 nt in the polymerase gene) of the
virus. A systematic selection of strains was also typed by
sequencing region C (277 nt in the capsid gene) (1,2).
Because NoV activity is much higher in winter months,
seasons were analyzed from July through June, rather than
per calendar year.
From December 18, 1993 to December 26, 2005, a
total of 1,032 gastroenteritis outbreaks were reported to the
RIVM. Samples from 942 outbreaks were received and
analyzed. Of these, 695 (74%) outbreaks met our inclusion
criteria for a NoV outbreak (≥25% of samples positive by
reverse transcription–PCR). Overall, we observed an
increasing trend in the number of reported outbreaks per
year (Figure, panel A). In the 1995–96, 2001–02, 2002–03,
and 2004–05 seasons, more NoV outbreaks were reported
(66, 90, 154, and 161, respectively). GGII virus strains
were predominant in all years and caused 577 (91%) of
631 outbreaks with known genotypes, compared with 36
(6%) of 631 outbreaks caused by GGI or GGIV viruses
and 18 (3%) of 631 outbreaks caused by mixed infections
with viruses of different genotypes (Table).
GGII.4 strains have been detected since 1995, with the
highest proportions observed in years with high numbers
of outbreaks. In the epidemic seasons of 1995–96,
2002–03, and 2004–05 the percentages of outbreaks
caused by GGII.4 were 82%, 83%, and 89%, respectively,
compared with an overall average of 68% (Figure). In sea-
sons after these epidemics, the percentage caused by
GGII.4 decreased to 39% in 1996–97,  55% in 2003–04,
and 32% in the first half of 2005–06. Multiple NoV geno-
types co-circulated throughout the years of the study, but
in postepidemic years, outbreaks caused by non-GGII.4
strains were more common (Figure, panel C). The high
number of outbreaks in 2001–02 may be partially
explained by emergence of a new variant of GGII.4 in the
spring of 2002 (4), which caused uncharacteristically high
numbers of outbreaks between April and June. The epi-
demic increases in the number of outbreaks and seasonali-
ty of outbreaks were mainly attributable to GGII.4. Strains
with genotypes other than GGII.4 were found at similar
levels throughout the year (data not shown).
A total of 548 (79%) outbreaks were reported in
healthcare settings (hospitals and residential institutions)
compared with 102 (15%) in nonhealthcare settings; for 45
(6%) outbreaks no data were available (Table). A total of
407 (81%) of 502 outbreaks with genotyping information in
healthcare settings were caused by GGII.4 NoV strains
(Table). In the nonhealthcare settings, GGII.4 was signifi-
cantly less prevalent (39 [43%] of 91, p<0.0001), resulting
in a relative risk at least 2.17× higher for acquiring a GGII.4
infection in a healthcare setting than in other settings.
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the NetherlandsA mode of transmission was reported for 272 (39%)
outbreaks. Data confirmed that the main transmission
route was person to person (60%, 163/272) (Table) (5,6).
GGII.4 strains were found in 73% of person-to-person out-
breaks compared with 44% of food-related outbreaks
(p<0.0001). When outbreaks for which no genotype was
known were counted as non-GGII.4 strains, the relative
risk of finding GGII.4 in an outbreak caused by person-to-
person transmission was 2.3× greater than finding it in a
foodborne outbreak or relative to other genotypes.
Multiple GGII NoV strains were found in 18 outbreaks (3
foodborne, 1 waterborne, 4 person-to-person, and 10 with
unknown modes of transmission).
Conclusions
Detailed molecular epidemiologic data from long-
term surveillance on NoV outbreaks are rare because NoV
molecular detection techniques became available only in
the mid-1990s. In our 12-year surveillance study, we
observed large differences in the magnitude of the annual
winter peak of NoV infection. All epidemic peaks were
associated with predominance of GGII.4 strains. Although
this finding has been observed in studies covering a short-
er period (3,5–7), our data suggest an increase in infections
with GGII.4 in recent years, particularly in healthcare set-
tings. However, the number of outbreaks reported in
healthcare settings is likely overrepresented in our study
because of mandatory reporting of illness in such settings.
An actual increase in the number of outbreaks cannot be
proven based on passive surveillance data alone, but an
increase is strongly suggested by increased prevalence of
GGII.4 in recent years and supported by reported shifts in
the predominant GGII.4 variant associated with large num-
bers of outbreaks (8).
The overall dominance of GGII.4 suggests that this
genotype is more transmissible than other genotypes in
healthcare settings, where close contact of many persons
favors person-to-person transmission. Transmission may
also be affected by poorer hygiene or greater susceptibili-
ty to infection. Increased transmissibility could result from
increased levels of shedding of GGII.4 or altered stability
of virus particles outside the host compared with other
genotypes. Alternatively, changes in circulating viruses
may lead to differences in host cell binding or immune
recognition, thereby changing the dynamics of infection or
size of the population at risk.
Our group and other researchers have reported the
emergence of distinct GGII.4 lineages in 1995–96, 2002,
and 2004 (2,4,9,10). This suggests that the changing phe-
notype of GGII.4 strains results in increased numbers of
outbreaks (10). A detailed characterization of GGII.4
strains is ongoing to determine the molecular mechanisms
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Figure. A) Number of norovirus outbreaks reported per month in
the Netherlands, 1994–2005. B) Total no. of outbreaks per season
and fraction of GGII.4 outbreaks reported in the Netherlands. Total
no. is indicated by the solid line, no. of GGII.4 outbreaks by the
dotted line (values on left y-axis), bars indicate percentage of
GGII.4 outbreaks of the total no. (values on right y-axis), and
arrows indicate epidemic seasons. Seasons run from July through
June. C) Total no. of genotypes (Gts) circulating per season.
Shading of the bar indicates the percentage of GGII.4, ranging
from white (0%–20%), in steps of 20%, to black (80%–100%).involved in observed epidemiologic patterns. The marked
decrease in the percentage of GGII.4 strains during sea-
sons after epidemic seasons caused by variant strains sug-
gests that populations may acquire immunity against these
predominant strains.
The value of this surveillance dataset will increase
with its continuation, as well as with its expansion as part
of a European surveillance network (www.eufoodborne
viruses.co.uk). Future research will be directed at under-
standing the molecular basis for observed changes in the
epidemiology of NoV and control of its spread.
Acknowledgments
We thank E. de Bruin and B. van de Veer for technical assis-
tance, L. Verhoef for assistance with statistical analysis, and  A.
Kroneman for assistance with databases.
This study was supported by the European Commission DG
Research Quality of Life Program, Sixth Framework (SP22-CT-
2004-502571).
Ms Siebenga is a PhD student at Erasmus University,
Rotterdam, the Netherlands, and works at the National Institute
for Public Health, Bilthoven, the Netherlands. Her research inter-
ests include the molecular epidemiology and evolution of
noroviruses.
References
1.  Vinje J, Koopmans MP. Molecular detection and epidemiology of
small round-structured viruses in outbreaks of gastroenteritis in The
Netherlands. J Infect Dis. 1996;174:610–5. 
2.  Vinje J, Altena SA, Koopmans MP. The incidence and genetic vari-
ability of small round-structured viruses in outbreaks of gastroen-
teritis in The Netherlands. J Infect Dis. 1997;176:1374–8. 
3.  Fankhauser RL, Noel JS, Monroe SS, Ando T, Glass RI. Molecular
epidemiology of “Norwalk-like viruses” in outbreaks of gastroen-
teritis in the United States. J Infect Dis. 1998;178:1571–8. 
4.  Lopman B, Vennema H, Kohli E, Pothier P, Sanchez A, Negredo A,
et al. Increase in viral gastroenteritis outbreaks in Europe and epi-
demic spread of new norovirus variant. Lancet. 2004;363:682–8. 
5.  Blanton LH, Adams SM, Beard RS, Wei G, Bulens SN, Widdowson
MA, et al. Molecular and epidemiologic trends of caliciviruses
associated with outbreaks of acute gastroenteritis in the United
States, 2000–2004. J Infect Dis. 2006;193:413–21. 
6.  Bon F, Ambert-Balay K, Giraudon H, Kaplon J, Le Guyader S,
Pommepuy M, et al. Molecular epidemiology of caliciviruses
detected in sporadic and outbreak cases of gastroenteritis in France
from December 1998 to February 2004. J Clin Microbiol.
2005;43:4659–64. 
7.  Gallimore CI, Green J, Lewis D, Richards AF, Lopman BA, Hale
AD, et al. Diversity of noroviruses cocirculating in the north of
England from 1998 to 2001. J Clin Microbiol. 2004;42:1396–401. 
8.  Kroneman A, Vennema H, van Duijnhoven Y, Duizer E, Koopmans
M. High number of norovirus outbreaks associated with a GGII.4
variant in the Netherlands and elsewhere: does this herald a world-
wide increase? Eurosurveillance Weekly. 2005;10:51-52.
9.  Noel JS, Fankhauser RL, Ando T, Monroe SS, Glass RI.
Identification of a distinct common strain of “Norwalk-like viruses”
having a global distribution. J Infect Dis. 1999;179:1334–44. 
10.  Bull RA, Tu ET, McIver CJ, Rawlinson WD, White PA. Emergence
of a new norovirus genotype II.4 variant associated with global out-
breaks of gastroenteritis. J Clin Microbiol. 2006;44:327–33. 
Address for correspondence: J. Joukje Siebenga, National Institute for
Public Health and the Environment, PO Box 1, 3720 BA Bilthoven, the
Netherlands; email: Joukje.Siebenga@rivm.nl
DISPATCHES
146 Emerging Infectious Diseases • www.cdc.gov/eid • Vol. 13, No. 1, January 2007
The print journal is available at no charge to public health professionals
YES, I would like to receive Emerging Infectious Diseases.
Please print your name and business
address in the box and return by fax to
404-639-1954 or mail to
EID Editor
CDC/NCID/MS D61
1600 Clifton Road, NE
Atlanta, GA 30333
Moving? Please give us your new address (in the box) and print the number of your old
mailing label here_________________________________________
	



